As of 2026-04-02, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -3.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 148.22 mil USD. AVITA's TTM EBITDA according to its financial statements is -39.82 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 15.8x | 15.0x |
| Forward P/E multiples | 19.3x - 25.4x | 21.1x |
| Fair Price | (26.16) - (21.63) | (24.53) |
| Upside | -793.8% - -673.8% | -750.7% |
| Date | EV/EBITDA |
| 2026-04-01 | -3.72 |
| 2026-03-31 | -3.67 |
| 2026-03-30 | -3.61 |
| 2026-03-27 | -3.76 |
| 2026-03-26 | -3.79 |
| 2026-03-25 | -3.89 |
| 2026-03-24 | -3.78 |
| 2026-03-23 | -3.86 |
| 2026-03-20 | -3.86 |
| 2026-03-19 | -3.92 |
| 2026-03-18 | -4.05 |
| 2026-03-17 | -4.26 |
| 2026-03-16 | -4.38 |
| 2026-03-13 | -4.21 |
| 2026-03-12 | -4.35 |
| 2026-03-11 | -4.51 |
| 2026-03-10 | -4.59 |
| 2026-03-09 | -4.64 |
| 2026-03-06 | -4.48 |
| 2026-03-05 | -4.50 |
| 2026-03-04 | -4.64 |
| 2026-03-03 | -4.52 |
| 2026-03-02 | -4.88 |
| 2026-02-27 | -4.69 |
| 2026-02-26 | -4.75 |
| 2026-02-25 | -4.67 |
| 2026-02-24 | -4.97 |
| 2026-02-23 | -4.55 |
| 2026-02-20 | -4.51 |
| 2026-02-19 | -4.19 |
| 2026-02-18 | -4.14 |
| 2026-02-17 | -4.14 |
| 2026-02-13 | -4.02 |
| 2026-02-12 | -3.68 |
| 2026-02-11 | -3.78 |
| 2026-02-10 | -3.90 |
| 2026-02-09 | -3.94 |
| 2026-02-06 | -3.82 |
| 2026-02-05 | -3.85 |
| 2026-02-04 | -3.96 |
| 2026-02-03 | -4.13 |
| 2026-02-02 | -4.08 |
| 2026-01-30 | -4.21 |
| 2026-01-29 | -4.18 |
| 2026-01-28 | -4.24 |
| 2026-01-27 | -4.34 |
| 2026-01-26 | -4.31 |
| 2026-01-23 | -4.24 |
| 2026-01-22 | -4.00 |
| 2026-01-21 | -3.81 |